DrugPatentWatch Database Preview
« Back to Dashboard
Rauwolfia Serpentina is a drug marketed by Bundy, Halsey, Impax Labs, Ivax Sub Teva Pharms, Purepac Pharm, Pvt Form, Solvay, Tablicaps, Valeant Pharm Intl, and Watson Labs. and is included in twelve NDAs.
The generic ingredient in RAUWOLFIA SERPENTINA is rauwolfia serpentina root. There are eight drug master file entries for this compound. Additional details are available on the rauwolfia serpentina root profile page.